IranPharma: A Beacon of Global Health Diplomacy and Innovation

IranPharma: A Beacon of Global Health Diplomacy and Innovation

TEHRAN – The 10th IranPharma Exhibition has emerged as a significant event for health diplomacy and international engagement in the pharmaceutical sector. This exhibition, which took place from September 24 to 26, is the first international gathering of its kind following the 12-day conflict in June. It has drawn a remarkable number of participants from both domestic and international pharmaceutical companies, highlighting the resilience and adaptability of Iran’s health sector.

As the largest specialized pharmaceutical event in Iran, the IranPharma Exhibition showcased a diverse array of exhibitors and visitors. The event welcomed pharmaceutical companies from a wide range of countries, including:

  • Argentina
  • Austria
  • Belgium
  • Canada
  • China
  • Czech Republic
  • England
  • France
  • Finland
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • India
  • United States
  • Italy
  • Japan
  • Peru
  • Spain
  • Netherlands
  • Poland
  • Portugal
  • South Korea
  • Switzerland
  • Sweden
  • Taiwan
  • Turkey
  • United Arab Emirates

This year saw a remarkable 30 percent increase in visitor numbers compared to previous years, signifying a growing interest in Iran’s pharmaceutical landscape. Currently, the Iranian pharmaceutical industry employs over 140,000 individuals, contributing significantly to the nation’s economy.

During the Iranian year 1403 (March 2024 – March 2025), medical exports are projected to rise by 16 percent compared to the previous year, with the first five months of the current Iranian year indicating an 11 percent increase in exports over the same period last year. The exhibition was hosted by the Iranian Syndicate of Pharmaceutical Industries at the Grand Musalla in Tehran, attracting a total of 373 domestic and 370 international companies, associations, and related organizations.

This year’s exhibition was themed “Sustainability, Resilience, and Innovation,” serving as a platform for domestic companies to address challenges in pharmaceutical manufacturing, showcase their export capabilities, and attract investment in innovative sectors. The event facilitated collaborative meetings and the signing of agreements with foreign companies, particularly from India and China.

The exhibition also featured several side events, including expert panels, business meetings, book exhibitions, and student tours, all of which drew considerable attention. Health Minister Mohammad-Reza Zafarqandi emphasized the government’s commitment to self-sufficiency in medicine and medical equipment production, stating, “We are trying to reach self-sufficiency for the supply of medicine and medical equipment.”

The head of Iran’s Union of Medical Equipment Manufacturers and Exporters revealed that medical equipment worth approximately $20 million is exported annually to over 60 countries. Abdolreza Yaqoubzadeh noted that more than 70 percent of medical equipment and 100 percent of standard hospital beds are produced domestically. In addition, over 95 percent of specific ICU and CCU beds, along with more than 85 percent of operating room medical equipment, including anesthesia machines, are manufactured using advanced technology within the country.

Yaqoubzadeh highlighted that Iran’s annual demand for medical equipment production stands at approximately $3 to $4 billion, with about $1 billion of that being met through imports. Currently, around 600 medical equipment companies operate within Iran, producing nearly 99 percent of the medicines available in the domestic market.

These manufacturers are capable of producing and supplying over 10,000 types of medical equipment for both domestic and international markets. Notably, various laboratory equipment is now manufactured in Iran at prices significantly lower than those of foreign counterparts, demonstrating the country’s growing capabilities in the healthcare sector.

The IranPharma Exhibition not only showcases the advancements in Iran’s pharmaceutical industry but also serves as a vital platform for fostering international cooperation and addressing global health challenges. As the country continues to focus on innovation and self-sufficiency, events like this will play a crucial role in shaping the future of healthcare in Iran and beyond.

Similar Posts

  • Iran Stands Firm: No Compromise on Enrichment Rights Amidst Bullying Pressures, Says Foreign Ministry Spokesperson

    Iran’s Foreign Ministry spokesperson Esmaeil Baqaei reaffirmed the country’s commitment to its right to uranium enrichment, stating Tehran will not relinquish this right. This statement comes amidst ongoing discussions regarding Iran’s nuclear program, with Baqaei addressing U.S. demands for a halt to enrichment. He emphasized that ensuring a non-weaponized program is achievable if the U.S. respects Iran’s right to peaceful nuclear energy. Baqaei highlighted several potential avenues for compromise, asserting that the Iranian people will not yield to threats. As negotiations progress, the future of Iran’s nuclear ambitions remains crucial for regional and international stability.

  • Iran and UN Champion Climate Justice: A Call for Global Action

    During the COP30 conference in Belém, Brazil, Iranian Environment Chief Shina Ansari and UN Secretary-General Antonio Guterres emphasized the importance of climate justice in the face of coercive sanctions affecting Iran’s environmental efforts. Ansari highlighted the need for international collaboration free from restrictions and discussed strengthening ties between Iran and Brazil, particularly in environmental matters. Guterres reiterated the need for equitable solutions to climate-related issues. The conference aims to address climate change through collective actions in key areas, including energy and agriculture, while promoting environmental diplomacy to resolve cross-border challenges like dust storms and resource management.

  • Staggering 980,000 Births Registered in a Single Year: A Remarkable Milestone!

    The Civil Registration Organization of Iran reported 979,923 births registered from March 2024 to March 2025, with Tehran province leading at 120,562 births and Ilam province having the lowest at 6,534. The average age of first-time mothers was 27.5 years, while fathers averaged 32.3 years, showing urban-rural discrepancies. Urban mothers averaged 28.2 years and fathers 32.8 years, compared to rural mothers at 24.4 years and fathers at 30 years. Officials stress the need to raise the fertility rate from 1.66 to 2.5 to address the aging population, advocating for youth-focused national programs and modern infertility treatments.

  • Iran Recognized as a Leader in High Human Development by UNDP

    The UNDP’s latest Human Development Report (HDR) 2025 highlights Iran’s position within the High Development Index (HDI) category, noting a slight decline in its HDI score from 0.780 to 0.779, ranking it 75th globally. Despite a significant increase in HDI from 1990 to 2023, concerns remain regarding gender inequality, with Iran’s GII score placing it 123rd out of 172 countries. The report warns of a global slowdown in human development, urging nations to take action amid escalating challenges. It advocates for a human-centered approach to AI, emphasizing collaboration and modernization in education and health systems to enhance development outcomes.

  • This article will be expanded with more detailed information shortly. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information…

  • Nowruz Brings Hope: Medical Assistance for Rare Disease Patients

    As Nowruz (New Year) holidays approach, Iran’s Ministry of Health will extend essential services for patients with hard-to-treat and rare diseases starting March 21. Key facilities, such as dialysis clinics, blood transfusion centers, and chemotherapy units, will remain operational during the festive period. Notably, 15 centers will offer 24/7 support for multiple sclerosis patients. The initiative aims to alleviate concerns for vulnerable populations, ensuring continuous healthcare access. With 442 documented rare diseases in Iran, the ministry emphasizes the importance of awareness and support for affected individuals and their families during this time, highlighting its commitment to public health.